James Schultz

Array ( [id] => 9320950 [patent_doc_number] => 20140053288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-20 [patent_title] => 'EPO KNOCKOUT GFP ANEMIC MOUSE' [patent_app_type] => utility [patent_app_number] => 14/008703 [patent_app_country] => US [patent_app_date] => 2012-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 10135 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10522894 [patent_doc_number] => 09249394 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-02 [patent_title] => 'Method for producing epithelial stem cells' [patent_app_type] => utility [patent_app_number] => 14/007133 [patent_app_country] => US [patent_app_date] => 2012-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 15 [patent_no_of_words] => 12902 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14007133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8289838 [patent_doc_number] => 20120178167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'Methods for Transfecting Nucleic Acid Into Live Cells' [patent_app_type] => utility [patent_app_number] => 13/426422 [patent_app_country] => US [patent_app_date] => 2012-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14205 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13426422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9273115 [patent_doc_number] => 08637042 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-28 [patent_title] => 'Targeted particles and methods of using the same' [patent_app_type] => utility [patent_app_number] => 13/422864 [patent_app_country] => US [patent_app_date] => 2012-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17643 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13422864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9386611 [patent_doc_number] => 20140090094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-27 [patent_title] => 'MODULATORS OF SLC22A7' [patent_app_type] => utility [patent_app_number] => 14/004027 [patent_app_country] => US [patent_app_date] => 2012-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 21021 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14004027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8197169 [patent_doc_number] => 20120121648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'RNA SEQUENCE MOTIFS IN THE CONTEXT OF DEFINED INTERNUCLEOTIDE LINKAGES INDUCING SPECIFIC IMMUNE MODULATORY PROFILES' [patent_app_type] => utility [patent_app_number] => 13/360894 [patent_app_country] => US [patent_app_date] => 2012-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 32458 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20120121648.pdf [firstpage_image] =>[orig_patent_app_number] => 13360894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10600280 [patent_doc_number] => 09320829 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-26 [patent_title] => 'Progenitor endothelial cell capturing with a drug eluting implantable medical device' [patent_app_type] => utility [patent_app_number] => 13/340338 [patent_app_country] => US [patent_app_date] => 2011-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 57 [patent_no_of_words] => 24070 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13340338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11772466 [patent_doc_number] => 09381219 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-05 [patent_title] => 'Brown adipocyte modification' [patent_app_type] => utility [patent_app_number] => 13/977543 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12959 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13977543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9503552 [patent_doc_number] => 08741864 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-03 [patent_title] => 'Gene expression and pain' [patent_app_type] => utility [patent_app_number] => 13/316321 [patent_app_country] => US [patent_app_date] => 2011-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 32093 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13316321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9280840 [patent_doc_number] => 20140030808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-30 [patent_title] => 'Method for Cellular RNA Expression' [patent_app_type] => utility [patent_app_number] => 13/990729 [patent_app_country] => US [patent_app_date] => 2011-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 26446 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13990729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8291814 [patent_doc_number] => 20120180142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'CLONED TRANSMEMBRANE RECEPTOR FOR 24-HYDROXYLATED VITAMIN D COMPOUNDS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/306599 [patent_app_country] => US [patent_app_date] => 2011-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21783 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13306599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8242892 [patent_doc_number] => 20120151612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'NON-SURGICAL APPROACH TO PREVENT AND CORRECT CRANIOFACIAL MALFORMATIONS DURING DEVELOPMENT' [patent_app_type] => utility [patent_app_number] => 13/296165 [patent_app_country] => US [patent_app_date] => 2011-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 29268 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13296165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9094245 [patent_doc_number] => 20130273556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-17 [patent_title] => 'MODULATION OF GENE EXPRESSION BY LOCKED NUCLEIC ACIDS' [patent_app_type] => utility [patent_app_number] => 13/882845 [patent_app_country] => US [patent_app_date] => 2011-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16608 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13882845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9134301 [patent_doc_number] => 20130295015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'Optically-Controlled CNS Dysfunction' [patent_app_type] => utility [patent_app_number] => 13/882719 [patent_app_country] => US [patent_app_date] => 2011-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 19685 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13882719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9086446 [patent_doc_number] => 08557875 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-15 [patent_title] => 'Gene transfer agent composition containing polyamidoamine dendron' [patent_app_type] => utility [patent_app_number] => 13/289423 [patent_app_country] => US [patent_app_date] => 2011-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 21 [patent_no_of_words] => 11887 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13289423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9120814 [patent_doc_number] => 20130287736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'GENE THERAPY FOR NEURODEGENERATIVE DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/287583 [patent_app_country] => US [patent_app_date] => 2011-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 22954 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13287583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10533827 [patent_doc_number] => 09259443 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-16 [patent_title] => 'Compositions and methods for the generation of platelets and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 13/881587 [patent_app_country] => US [patent_app_date] => 2011-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 27 [patent_no_of_words] => 10089 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13881587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11548679 [patent_doc_number] => 09617514 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-11 [patent_title] => 'Downregulation of SINE/ALU retrotransposon transcription to induce or restore proliferative capacity and/or pluripotency to a stem cell' [patent_app_type] => utility [patent_app_number] => 13/880969 [patent_app_country] => US [patent_app_date] => 2011-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 57 [patent_no_of_words] => 31425 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13880969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8140743 [patent_doc_number] => 20120094925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 7 FOR TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/269091 [patent_app_country] => US [patent_app_date] => 2011-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 17935 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20120094925.pdf [firstpage_image] =>[orig_patent_app_number] => 13269091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9036598 [patent_doc_number] => 20130239236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-12 [patent_title] => 'Regulation of translation of expressed genes' [patent_app_type] => utility [patent_app_number] => 13/877259 [patent_app_country] => US [patent_app_date] => 2011-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 28210 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13877259 [rel_patent_id] =>[rel_patent_doc_number] =>)